Total planned funding: $174,360,788
Allocations
Countries/Regions
Eswatini | $174,360,788 |
Organizational Types
NGO | $40,034,897 |
Private Contractor | $35,696,749 |
Unknown | $35,383,082 |
University | $33,693,749 |
Own Agency | $18,805,568 |
Host Country Government Agency | $6,543,560 |
Multi-lateral Agency | $1,583,840 |
Other USG Agency | $1,286,843 |
FBO | $742,500 |
Implementing Agency | $590,000 |
Program Areas
Care | $53,595,739 |
Prevention | $37,988,695 |
Treatment | $32,086,995 |
Governance and Systems | $25,953,100 |
Management and Operations | $12,963,584 |
Testing | $11,772,675 |
Budget Codes
HTXS: Treatment: Adult Treatment | $25,627,007 |
HBHC: Care: Adult Care and Support | $24,359,724 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,935,293 |
HKID: Care: Orphans and Vulnerable Children | $13,923,164 |
HVMS: Management and Operations | $12,963,584 |
HVSI: Strategic Information | $11,778,887 |
HVCT: Testing: HIV Testing and Counseling | $11,772,675 |
HVTB: Care: TB/HIV | $10,437,917 |
OHSS: Health Systems Strengthening | $9,781,751 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,566,199 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,267,604 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,457,599 |
PDCS: Care: Pediatric Care and Support | $4,874,934 |
HLAB: Laboratory Infrastructure | $4,392,462 |
HTXD: Treatment: ARV Drugs | $3,389,187 |
PDTX: Treatment: Pediatric Treatment | $3,070,801 |
HMBL: Biomedical Prevention: Blood Safety | $762,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$34,880,095
Countries/Regions
Columbia University:
$31,143,358
Countries/Regions
Pact, Inc.:
$19,531,428
Countries/Regions
USG Aggregated Agencies:
$16,299,940
Countries/Regions